C82.4
Follicular lymphoma grade IIIb
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma grade IIIb is a type of non-Hodgkin lymphoma, a cancer that begins in the lymphatic system. Specifically, it involves abnormal growth of lymphocytes, a kind of white blood cell that plays a vital role in the immune system. This particular grade, IIIb, indicates an aggressive form of follicular lymphoma characterized by densely packed large abnormal cells. Although it shares features with indolent forms, grade IIIb lymphoma tends to progress more rapidly, requiring prompt medical attention and treatment planning.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphocytes that cause abnormal cell growth Age-related changes, as it is more common in older adults Possible environmental exposures, though specific links are not well established Immune system dysfunction, which can influence lymphocyte behavior History of other lymphoproliferative disorders
Key Symptoms: Painless swelling in lymph nodes, commonly in the neck, armpits, or groin Unexplained weight loss Persistent fever without infection Night sweats Fatigue and weakness Sometimes, symptoms related to affected organs, such as abdominal pain or chest discomfort
Diagnostic & Treatment
Diagnosis Path: Physical examination to identify swollen lymph nodes and other signs Blood tests to evaluate overall health and detect abnormalities Lymph node biopsy, which provides tissue samples for microscopic evaluation, confirming the presence and type of lymphoma Immunohistochemistry and molecular studies to determine the specific grade and subtype Imaging studies such as CT scans, PET scans, or MRI to assess the extent of disease spread Bone marrow biopsy if the disease has potentially involved the marrow
Treatment Protocols: Chemotherapy, often combined with targeted therapies like monoclonal antibodies (e.g., rituximab) Immunotherapy to bolster the immune response against cancer cells Radioimmunotherapy, which combines radiation therapy with immunotherapy Targeted drug therapies that interfere with specific molecules involved in lymphoma growth Stem cell or bone marrow transplants in select cases, especially if the disease is aggressive or relapses after initial treatment Supportive care to manage symptoms and maintain overall health, including medications and lifestyle adjustments
Clinical Advice & FAQs
Billing Guidance
Is C82.4 a billable ICD-10 code?
Yes, C82.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.4?
Clinical documentation must specify the nature of Follicular lymphoma grade IIIb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference